𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trials in head and neck oncology: An evaluation of clinicians' willingness to participate

✍ Scribed by Jane M. Young; Christopher O'Brien; James D. Harrison; Michael J. Solomon

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
315 KB
Volume
28
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Background. This study investigated the individual and collective (''community'') equipoise of surgeons and oncologists and their willingness to take part in each of six hypothetical randomized controlled trials in head and neck oncology.

Methods. A survey was mailed to Australasian head and neck specialists.

Results. Among 109 respondents (74% response), the scenario with the highest level of individual equipoise pertained to the use of adjuvant interferon for patients with high-risk malignant melanoma, with 45% indicating complete uncertainty between treatment approaches. Significant differences in levels of community equipoise were demonstrated between surgeons and oncologists for three of the scenarios. Willingness to participate in randomized controlled trials ranged from 39% to 72%. Increasing strength of treatment preference was associated with unwillingness to participate in randomized controlled trials for two of six scenarios.

Conclusion. High levels of equipoise and willingness to participate in clinical research augur well for future randomized controlled trials in head and neck oncology.

πŸ“œ SIMILAR VOLUMES

Importance of patient examination to cli
Importance of patient examination to clinical quality assurance in head and neck radiation oncology
✍ David I. Rosenthal; Joshua A. Asper; Jerry L. Barker Jr.; Adam S. Garden; K. S. πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 2 views

## Abstract ## Background. When quality assurance programs in clinical radiation oncology focus mainly on the technical aspects of treatment, they tend to underplay questions of therapeutic process and outcome. We determined the value of clinical peer review in radiation therapy for head and neck

Surgical margin determination in head an
Surgical margin determination in head and neck oncology: Current clinical practice. The results of an International American Head and Neck Society Member Survey
✍ Jeremy D. Meier; Dana A. Oliver; Mark A. Varvares πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 156 KB πŸ‘ 2 views

Background. Our aim was to investigate the ways in which surgeons who perform head and neck ablative procedures on a regular basis define margins, how they use frozen sections to evaluate margins, and the effect of chemoradiation on determining tumor margins. Methods. A custom-designed questionnair

Clinical utility of PET/CT in the evalua
Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial
✍ Luke Rudmik; Harold Y. Lau; T. Wayne Matthews; J. Douglas Bosch; Reinhard Kloibe πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 2 views

## Abstract ## Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. ## Methods In all, 20 sub

Final report of a phase II evaluation of
Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : An Eastern Cooperative Oncology Group trial (PA390)
✍ Arlene A. Forastiere; Darleen Shank; Donna Neuberg; Samuel G. Taylor IV; Ronald πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.